e-mail

office.cidr@iisc.ac.in

News

2024

  • Rohan Gets a travel award and the invitation to deliver a research talk at the ‘Pandemic Preparedness’ conference in ICGEB Trieste (Link)
  • Oyahida goes to present a research poster at the Keystone Positive Strand RNA Virus Meeting in Killarney, Ireland. (Link)
  • Shashank delivers a research talk at Immunocon 2024 at IISc, Bengaluru. (Link)
  • Oyahida gets SERB Internationa Travel Award to attend Keystone Positive Strand RNA Virus Meeting in Killarney, Ireland. (Link)
  • Shashank gets the Axis Bank International Travel Award to attend the Options XI meeting in Brisbane, Australia. (Link)
  • Shashank gets invited to chair a session and present research at the Options XI meeting in Brisbane, Australia. (Link)
  • Shashank goes to Sumit Chanda’s lab at Scripps Research, San Diego, USA, for a 3-month research Visit. (Link)
  • Mansi gets a travel award and invitation to deliver a talk and present a poster at ASV 2024 in Columbus, Ohio, USA. (Link)

2023

  • Uncovering the role of key SARS-CoV-2 protein in blocking host immunity
  • How SARS-CoV-2 protein blocks host’s immunity
    https://www.deccanherald.com/science/how-sars-cov-2-protein-blocks-hosts-immunity-2819876
  • Invited Talk at Russian Academy of Science Meeting Moscow (2nd November 2023) – Dr Shashank Tripathi is invited to give a talk at the Russian Academy of Science Meeting held in Moscow, Russia.
  • INSA Associate Fellowship Award 2023 (October 2023) – Dr Shashank Tripathi is awarded INSA Associate Fellowship Award 2023.
  • Invited Talk At Molecular Virology Meeting 2023 (22nd September 2023) – Dr Shashank Tripathi is invited to give a talk at 7th Molecular Virology Meeting held in IISc Bangalore.
  • Travel Grant for Rohan Narayan (17th September 2023) – Dr Rohan Narayan is awarded Travel Grant to attend the 9th ESWI Influenza Conference in Valencia, Spain.
  • Featured in The New Indian Express (19 July 2023) – New of our published work on the discovery of a Broad-Spectrum Antiviral got covered by The New Indian Express under the title “Picolinic acid can block Covid, flu viruses: Study” (Link)
  • Featured in The Hindu (18 July 2023) – New of our published work on the discovery of a Broad-Spectrum Antiviral got covered by The Hindu under the title “ IISc study reveals that picolinic acid can block viruses causing SARS-CoV-2 and influenza A” (Link)
  • Featured in The Times of India (18 July 2023) – New of our published work on the discovery of a Broad-Spectrum Antiviral got covered by The Times of India under the title “Picolinic acid, a natural compound in humans, can block viruses like SARS-CoV-2:IISc” (Link)
  • Featured in BioSpectrum India (18 July 2023) – New of our published work on the discovery of a Broad-Spectrum Antiviral got covered by BioSpectrum India under the title “IISc unveils broad-spectrum antiviral abilities of picolinic acid” (Link)
  • Official Press Release by IISc (18 July 2023) – IISc release an official Press Release on our published work on the discovery of a Broad-Spectrum Antiviral in Cell Reports Medicine titled “Study unveils picolinic acid’s broad-spectrum antiviral abilities”(Link)
  • Travel Grant for Oyahida Khatun (24th June 2023) – Oyahida Khatun is awarded “Travel Award” at the 42nd American Society of Virology Conference held in Athens, Georgia, USA.
  • Featured in Telangana Today (19th May 2023) – News of our published work on enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology work on got covered by Telangana Today under the title “IISc study shows enhanced recombination boosting the spread of SARS-CoV-2”(link)
  • Featured in Biovoice(24th March 2023) – News of our published work enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology work on got covered by Biovoice under the title “Genetic recombination made Omicron more infectious”(Link)
  • Featured in India Science Wire of Vigyan Prasar (23rd March 2023) – News of our enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology work on got covered by India Science Wire of Vigyan Prasar under the title “Genetic recombination made Omicron more infectious”(Link)
  • Featured in News Karnataka(22nd March 2023) – News of our published work on Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology got covered by News Karnataka News titled “Bengaluru: ‘Hiked recombination boosting SARS-CoV-2 spread’(Link)
  • Featured in Greater Kashmir (22nd March 2023) – News of our published work on Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology got covered by Greater Kashmir News titled “ IISc study shows enhanced recombination boosting the spread of SARS-CoV-2”(Link)
  • Featured in Prokerala(21st March 2023) – News of our published work on enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology work on got covered by Prokerala under the title “IISc study shows enhanced recombination boosting the spread of SARS-CoV-2”(Link)
  • Featured in IANSlive(21st March 2023) – News of our published work on Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology got covered by IANSlive news titled “ IISc study shows enhanced recombination boosting the spread of SARS-CoV-2”(Link)
  • Featured in The Healthy Indian Project (21st March 2023) – News of our published work on Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology got covered by The Healthy Project titled “ IISc study shows enhanced recombination boosting the spread of SARS-CoV-2”(Link)
  • Official Press Release by IISc(20th March 2023) – IISc released an official Press Release on our published work regarding Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in the Journal of Medical Virology titled “Enhanced recombination: A shot in the arm for SARS-CoV-2 ”(Link)
  • Featured in The Times of India(20th March 2023) – News of our published work on Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology got covered by The Times of India News titled “ Enhanced recombination: A shot in the arm for SARS-CoV-2: IISc study”(Link)
  • Featured in The Hindu(20th March 2023) – News of our published work on Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology got covered by The Hindu News titled “ Enhanced recombination: A shot in the arm for SARS-CoV-2: IISc researchers”(Link)
  • Featured in The Economic Times(20th March 2023) – News of our published work on Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology got covered by The The Economic Times News titled “ Enhanced recombination: A shot in the arm for SARS-CoV-2 ”(Link)
  • Featured in Deccan Herald (20th March 2023) – News of our work enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology work on got covered by Deccan Herald under the title “IISc research identifies mechanisms behind emergence of new Covid strains”(Link)
  • Featured in EurekaAlert.org(20th March 2023) – News of our published work on Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in Journal of Medical Virology got covered by EurekaAlert News titled “ Enhanced recombination: A shot in the arm for SARS-CoV-2 ”(Link)
  • Press Release by IISc in Medical Xpress (25th April 2022) – IISc published a press release of our work regarding enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape in the Journal of Medical Virology titled “Enhanced recombination among omicron variants shown contributes to viral immune escape, finds study”(Link)
  • Travel Grant for Rajesh Yadav (2nd February 2023) – Rajesh Yadav is awarded “Travel Grant” to attend International Vaccinology Course held in Institut Pasteur, Paris, France from 2nd February 2023 to 10th February 2023.
  • Invited Talk at BTMO Conference 2023 (21st January 2023) – Dr Shashank Tripathi is invited to give a talk at BTMO 2023 Conference held in IISc Bangalore.

 

2022

  • PMRF Award(25th October 2022) – Aditi Kanojia is awarded the Prime Minister’s Research Fellowship (PMRF)
  • FICCI- PMRF Award(1st September 2022)– Rishad Shiraz is awarded the Prime Minister’s Research Fellowship (PMRF)
  • Featured in EurekaAlert.org (5th October 2022) – News of our published work on the identification of flu-fighting pathways and genes essential for influenza A immune defense got covered by EurekaAlert.org (Link)
  • Publication in Science Advances (5th October 2022) – Research article co-authored by Dr Shashank Tripathi titled “Common and species-specific molecular signatures, networks, and regulators of influenza virus infection in mice, ferrets, and humans” got published in Science Advances (Link)
  • Invited for Oral Presentation at the ASV’s 41st Annual Meeting (16th July 2022) – Dr Shashank Tripathi is invited for an oral presentation entitled “Meta-analysis of COVID-19 OMICs data followed by validation in patient cohort reveals highly sensitive prognostic signature and FDA approved therapeutic target” at the American Society for Virology’s 41st Annual Meeting, held at the Monona Terrace in Madison.
  • Invited Talk At UK-ICN Conference (11th May 2022) – Dr Shashank Tripathi is invited to give a talk at the UK-ICN(UK-International Coronavirus Network) Conference titled “Coronaviruses: Past, Present and Future” held in SKUAST, Jammu and Kashmir.
  • Best Oral Presentation Award for Abhijith Biji (11th May 2022) – Abhijith Biji is awarded the “Best Oral Presentation Award” at the UK-ICN(UK-International Coronavirus Network) Conference titled “Coronaviruses: Past, Present and Future” held in SKUAST, Jammu and Kashmir.
  • Travel Grant for Abhijith Biji (11th May 2022) – Abhijith Biji is awarded “Travel Grant” at the UK-ICN(UK-International Coronavirus Network) Conference titled “Coronaviruses: Past, Present and Future” held in SKUAST, Jammu and Kashmir.
  • Featured in The Times of India (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by The Times of India titled “Asthma drug can block crucial SARS-CoV2 protein, says IISc” (Link)
  • Featured in BusinessToday (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by International BusinessToday.in titled ” Asthma drug found effective against COVID-19; here’s how it works” (Link)
  • Featured in News18 (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by News18 in titled “Corona can be prevented from changing its appearance, study in India revealed” (Link)
  • Featured in Dainik Bhaskar (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by Dainik Bhaskar titled “IISc: Asthma drug capable of inhibiting the spike protein of coronavirus” Link
  • Featured in The Print (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by The Print titled ” Asthma drug blocks coronavirus from replicating, IISc study finds” (Link)
  • Featured in DNA India (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by DNA India titled ” Asthma drug found to block coronavirus from replicating: IISc Bengaluru study.”
  • Featured in First India News(26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by First India News titled “ According to the study, the asthma drug disrupts the copies of the coronavirus ” (Link)
  • Featured in Samakalikamalayalam (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by Samakalikamalayalam titled “Asthma drug fights Covid, hospital stay reduced; Research” (Link)
  • Featured in Newswise (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by Newswise titled “Asthma drug can block crucial SARS-CoV-2 protein” (Link)
  • Featured in International Business Times (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by International Business Times titled ” This asthma drug is capable of blocking coronavirus from replicating” (Link)
  • Press Release by IISc in EurekaAlert (25th April 2022) – IISc published a press release of our collaborative work regarding the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 in EurekaAlert titled “Asthma drug can block crucial SARS-CoV-2 protein” (Link)
  • Featured in Zee News (25th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by Zee News titled “Asthma Drug On Corona: Claim! Asthma drug able to inhibit spike protein of corona” (Link)
  • Press Release by IISc in Medical Xpress (25th April 2022) – IISc published a press release of our collaborative work regarding the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 in Medical Xpress titled “Asthma drug can block crucial SARS-CoV-2 protein” (Link)
  • Featured in Economic Times (25th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by Economic Times titled “IISc researchers find Asthma drug Montelukast can block crucial SARS-CoV-2 protein” (Link)
  • Featured in TimesNowNews (25th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by TimesNowNews titled “Asthma drug could block coronavirus from replicating: Study” (Link)
  • Featured in IndiaToday (25th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by IndiaToday titled “Asthma drug blocks coronavirus from replicating, finds study” (Link)
  • Featured in 10TV (26th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by 10TV in titled “Asthma Medicines: Covid is a drug used in the treatment of asthma” (Link)
  • Featured in LiveMint (25th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by LiveMint.com titled “IISc scientists say Asthma drug Montelukast can reduce Covid virus from replicating” (Link)
  • Featured in Latestly (25th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by Latestly in titled “IISc claims, Asthma drug capable of inhibiting spike protein of coronavirus” (Link)
  • Official Press Release By IISc (25th April 2022) – IISc released an official press release on our collaborative work regarding the antiviral property of Montelukast drug targeting the Nsp1-ribosomal complex of SARS-CoV-2 (Link)
  • Featured in The Hindu (25th April 2022) – News of our collaborative work on the antiviral property of Montelukast drug targeting Nsp1-ribosomal complex of SARS-CoV-2 got covered by The Hindu under the title “Asthma drug can block crucial SARS-CoV-2 protein: IISc study” (Link)
  • Publication in eLife (24th March 2022) – Research article on a drug targeting Nsp1-ribosomal complex showing antiviral activity against SARS-CoV-2 got published in eLife.
  • Featured in Deccan Herald (23rd February 2022) – News of our preprint on the discovery of Broad-Spectrum Antiviral got covered by Deccan Herald under the title “IISc scientists find a compound in mammals that can restrict coronavirus” (Link)
  • Featured in Jansatta(22nd February 2022) – News of our preprint on the discovery of Broad-Spectrum Antiviral got covered by Jansatta (Link)
  • Featured in NewsMedical.net (21st February 2022) – News of our preprint on the discovery of Broad-Spectrum Antiviral got covered by NewsMedical.net (21st February 2022)(Link)
  • Featured in Telegraph (19th February 2022) – News of our preprint on the discovery of Broad-Spectrum Antiviral got covered by Telegraph titled “Covid: Hope of antiviral shield against multiple viruses” (Link)

2021

  • Quoted by Down To Earth (21st December 2021) – Shashank Tripathi got quoted in Down To Earth article titled ‘COVID-19 immunity: Treading turbulent waters’  Link
  • Official Press Release by IISc (14th November 2021) – IISc release an official Press Release on our published work on the identification of COVID-19 severity marker Link
  • Highlighted on KERNEL Research News IISc (14th November 2021) – “Leads for COVID-19 Prognosis and Therapy from Nasal Swabs got highlighted on KERNEL Research News IISc. Link
  • Publication in Critical Reviews in Immunology(October 2021) – A review article titled “Innate Immune Subversion Strategies of Human Flaviviruses” authored by Sumandeep Kaur and Shashank Tripathi, got published in the journal Critical Reviews in Immunology.
  • Publication in Nature Microbiology (23rd September 2021) – A research article co-authored by Dr Shashank Tripathi on a mechanism for evasion of autophagy got published in Nature Microbiology titled “Restriction Factor compendium for Influenza A virus reveals a mechanism for evasion of autophagy” Link
  • Featured in Hindustan Times(29th August 2021) – Our published work on the identification of COVID-19 severity marker got featured in the India News section of Hindustan Times titled, “IISc researchers identify marker to determine Covid severity.” Link
  • Featured in Deccan Herald(24th August 2021) – Our peer-reviewed work of identifying a novel marker for the prediction of Covid-19 severity, merely through RT PCR test got featured in Deccan Herald titled, “RT-PCR can predict Covid severity: IISc study”(
  • Featured by India Alliance(20th August 2021) Our published work on the identification of COVID-19 severity marker got covered by India Alliance Link
  • Top 5 in BRICS Young Scientist Conclave 2021 – Rajesh got selected in the top 5 for BRICS Young Scientist Conclave 2021
  • Featured in Jansatta (13th August 2021) – Our published work on the identification of COVID-19 severity marker got featured in the Jansatta Link
  • Publication in Lancet EBioMedicine (12th August 2021) – Abhijith and Oyahida’s Research article on the identification of COVID-19 severity marker got published in EBioMedicine(The Lancet)
  • Publication in ACE Infectious Disease(14th July 2021) – Research article co-authored by Dr Shashank Tripathi got published in ACE Infectious Disease-Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative Link
  • Official Press Release By IISc (1st July 2021) – IISc released an official press release on the COVID-19 Vaccine Testing Center titled “Viral BSL-3 facility and DBT-BIRAC COVID-19 Vaccine Testing Centre at IISc” Link
  • Featured in The Indian Express (1st July 2021) – The COVID-19 vaccine testing centre got covered in The Indian Express under the title “Karnataka: IISc’s Covid vaccine testing facility in Bengaluru first to be supported by BIRAC in south India” Link
  • Featured in Deccan Herald (29th June 2021) – The COVID-19 vaccine testing centre got covered in Deccan Herald under the title Vaccine testing centre started at BSL-3 lab at Bengaluru’s IISc. Link
  • Featured in The Hindu (26th June 2021) – The COVID-19 vaccine testing centre got covered in The Hindu under the title “COVID-19 vaccine testing centre set up at IISc” Link
  • Interviewed by Rediff (31st March 2021) – Shashank Tripathi got interviewed by Rediff, published under the title ‘One must be cautious, not scared, of the new variants’ Link
  • Public outreach publication in The Times of India(4th March 2021) – Abhijith and Dr Shashank Tripathi published an article in Times of India Article Titled “Lessons from a century-old pandemic for current India” Link
  • New Lab Members (22nd February 2021) – Rishad Shiraz joins the lab as a PhD student.

2020

  • Publication in Expert Review of Anti-infective Therapy (7th December 2020) –Shachee’s and Shashank’s review article gets published in Expert Review of Anti-infective Therapy titled “Novel Coronavirus (COVID-19) Pandemic: Current Status and Possible Strategies for detection and treatment of the disease” Link
  • The Lab Organizes CIDR Annual Symposium 2020(10th November 2020) – Our Lab organizes the “Combating COVID-19” Symposium with eminent international and national speakers.
  • PMRF Award(19th October 2020) – Shachee is awarded the Prime Minister’s Research Fellowship (PMRF)
  • Quoted by NBC News (3rd October 2020) – Shashank Tripathi got quoted in the NBC News Article titled ‘India’s coronavirus death toll passes 100,000 as cases continue to rise’ Link
  • Highlighted on KERNEL Research News IISc (1st September 2020) – “Novel Method for Live Imaging of Influenza Infection” got highlighted on KERNEL Research news IISc Link
  • Featured in Rajasthan Patrika (1st September 2020) – “Live Visualization of Hemagglutinin Dynamics During Infection by Using a Novel Reporter Influenza A Virus” got featured in Rajasthan Patrika Link
  • Publication in Nature Microbiology (24th August 2020) – Research article co-authored by Shashank on IFIT2 gets published in Nature Microbiology Link
  • Quoted by Nature News (21st July 2020) – Shashank Tripathi got quoted in the Nature News article titled ‘Coronavirus vaccines get a biotech boost’ Link
  • New Lab Members(1st July 2020) – Rishav and Aditi join the lab as integrated PhD. Students. Sumandeep joins as a PhD student.
  • Publication in Viruses(26th June 2020) – Oyahida’s paper on Influenza Live imaging is accepted in Viruses. (Link)
  • New Lab Members(7th May 2020) – Swarnima (BHU) and Manish (Amity, Noida) join the lab for their Master’s thesis.
  • COVID-19 Diagnostic Lab becomes operational(4th May 2020) – COVID-19 Diagnostic Lab becomes Operational in CIDR, IISc (Link)
  • Spotlight By Wellcome Trust-India Alliance (1st May 2020) – Shashank is featured as a fellow in the spotlight by Wellcome trust-India Alliance Link
  • Article Appears On COVID-Gyan Website (1st May 2020) – Shachhee and Abhijith’s article on COVID-19 appears on the COVID-Gyan website Link
  • Awsar Prize For Oyahida (31st March 2020) – Oyahida is awarded the Awsar Prize for her essay “Peeping into the dressing room of Influenza Virus”
  • Interviewed by Hindustan Times(20th march 2020) – Shashank is interviewed by Hindustan Times on COVID-19 Link
  • Quoted in Hindustan Times (19th March 2020) – Shashank got quoted in the Hindustan Times article titled ‘Covid-19 not created in a lab, has natural origins, say scientists’ Link
  • Interviewed by Deccan Herald (15th March 2020) – Shashank is interviewed by Deccan Herald on COVID-19 Link
  • Interviewed by Rediff.com(13th March 2020) – Shashank is interviewed by rediff.com on COVID-19 published under the title ‘Questions on coronavirus answered’ Link
  • Lecture On COVID-19(13th March 2020) – Shashank delivers a lecture on COVID-19 at MES Society, Bangalore
  • Carnegie India’s Discussion On COVID-19 (4th March 2020) – Shashank is invited to Carnegie India’s discussion on COVID-19  Link
  • IISc Open Day (29th February 2020) – The coronavirus exhibition is a big draw on the IISc Open Day 2020  Link.
  • Viruses 2020 – Novel Concepts In Virology (5th February 2020) – Shashank goes to the Viruses 2020 meeting in Barcelona Link
  • New Lab Members (7th January 2020) – Shachee and Rajesh join the lab as PhD students.

2019

  • New Lab Members (28th December 2019) – Abhijith and Rohan join the lab.
  • Carnegie India’s Panel Discussion On Pandemic Preparedness (6th December 2019) – Shashank participates in Carnegie India’s panel discussion on Pandemic Preparedness Link
  • Shashank’s Co-Authored Paper In Plos Pathogens (4th November 2019) – Shashank’s co-authored paper on ELF1 from Meike Dittman’s lab at NYU is published in Plos Pathogens Link
  • Invited Talk At Hong Kong University(9th September 2019) – Shashank deliver an invited talk at Hong Kong University, Pasteur Institute Link
  • Options X Meeting (28th August 2019) – Shashank goes to the Options X meeting in Singapore Link
  • Publication in Vaccines (14th August 2019) – Mansi’s Review titled “Moving from Empirical to Rational Vaccine Design in the ‘Omics’ Era” got published in Vaccines. Link
  • New Lab Members(1st May 2019) – Janvi and Shivpriya from MSU Baroda join the lab for their Master’s thesis.
  • Shashank is awarded Infosys Young Investigator Award (2nd April 2019)
  • First Members Of The Lab (1st March 2019) – Mansi and Oyahida join the lab for Integrated PhD students and Arpita joins the lab as a Postdoctoral Fellow
  • Shashank is awarded the DBT-Wellcome Trust India Alliance Intermediate Fellowship (1st February 2019). Link
  • Inauguration Of Infosys Wing (25th January 2019) – Infosys Wing is inaugurated in the Center for Infectious Disease Research. Link
  • Inception Of Emerging Viral Pathogens Lab (1st January 2019) – Shashank joins the Microbiology & Cell Biology Department of IISc as Assistant Professor. Link